Aphria Inc (NYSE: APHA), which has spurned a takeover attempt by Green Growth Brands Inc (OTC: GGBXF), announced Monday that it received approval from Health Canada to beef up its production capacity.
What Happened
Health Canada has granted Aphria a license amendment that will allow it to start production in an additional 800,000 square feet at its Aphria One location following the completion of Part IV and Part V expansions, the company said.
Aphria One is a greenhouse the cannabis grower operates in Leamington, Ontario, which accounts for the bulk of its production.
Once fully operational, Aphria said the expanded operation will produce an incremental 80,000 kg on an annualized basis, bringing the total production capacity at Aphria One to 110,000 kg.
The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Danny Moses, Alan Brochstein and many others.
Why It's Important
The procurement of the Health Canada license comes at an important juncture for Aphria, as it is fighting short-seller allegations that it is a shell company, with a cannabis business on the side.
The company also received flak for its acquisition of Latin American assets, with short sellers alleging that it benefited insiders and is not in the best interest of the company.
Additionally, Aphria is in the process of warding off an unsolicited offer from Green Growth brands, which the former feels significantly undervalues the company.
"Aphria's progress expanding production and automation is essential to our strategy of securing scale and long-term advantages that enable the evolution of the cannabis industry through product and brand innovation," interim CEO Irwin Simon said in a statement.
"With Aphria One, we now have the ability to expand our production capacity by over three times."
What's Next
Aphria expects growing operations in the expanded facilities to commence without delay, as it has already used its previously approved capacity for growing mother and vegetative plants to be used as initial growing crops in Part IV and Part V.
"By this Friday, we will move swiftly to establish nearly 22,000 plants in the Part IV and Part V expansion, with an additional 12,000 plants added each week thereafter until we reach full crop rotation," the company said.
Aphria shares were up 2.96 percent at $10.44 at the time of publication Monday.
Related Links:
APA Asks Attorney General To Speed Up Processing Of Cannabis Cultivation Licenses
Jamaican Cannabis Company Jacana Raises Million, Completes First Export
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.